Clinical Trials in San Francisco

Showing 2981-3000 of 12,991 trials

Severe Asthma Research Program

NCT01606826

The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.

Asthma

Milton S. Hershey Medical Center1,100 participantsStarted Oct 2012

San Francisco, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +5 more locations

RECRUITING< 1 mile

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

NCT07123038

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Sonoma Biotherapeutics, Inc.36 participantsStarted Jul 2025

San Francisco, California, United States • Stanford, California, United States • Aurora, Colorado, United States +7 more locations

Severe Asthma Research Program

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Find Trials by Condition in San Francisco

Accuracy Of The Owlet OSS 3.0 During Standardized Stable Hypoxia Plateaus

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Phase 1/2 Trial of ADI-270 in ccRCC

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Expanded Access of Sotorasib

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours